Early Prediction of Parkinson's Disease Progression by Integrating Research Cohort and Real-World Data Using Knowledge-Anchored Graph Learning
Yan, Z.; Li, H.; Huang, Z.; Zhou, M.; Wang, W.-T.; Jiang, S.; Zhang, M.; Martinez-Nunez, E.; Marongiu, R.; Sarva, H.; Okun, M. S.; Zhou, J.; Su, C.; Wang, F.
Show abstract
Parkinson disease (PD) progression is highly heterogeneous. Deeply phenotyped longitudinal research cohorts have enabled characterization of PD progression trajectories. Early prediction of these progression patterns can help us better understand patient disease conditions and manage appropriately. However, the sample sizes of these cohorts are typically too small to build robust early predictors, and it is usually challenging to translate them to real-world patients because of differences in the population as well as information availability. In this paper we present MedStitcher, a graph-based machine learning framework that stitches individual multimodal data across research cohorts and real-world data (RWD) using a biomedical knowledge graph-anchored architecture. This design enables predictive modeling under modality missingness and cross-dataset population heterogeneity. On the research cohort data combining PPMI and PDBP, MedStitcher achieved an AUROC of 0.819 +/- 0.040 for predicting rapid PD progressors, outperforming existing machine learning approaches. Graph-based model interpretation revealed clinical and molecular signals involving cognitive vulnerability, alpha-synuclein biology, vesicle trafficking and neuroinflammation. Importantly, MedStitcher-predicted rapid progressors in the RWD cohort demonstrated elevated risks of dementia, falls, mild cognitive impairment, and gait impairment, which also enabled identification of early indicators of rapid PD progression in real-world patient populations.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Integrating deep learning and unbiased automated high-content screening to identify complex disease signatures in human fibroblasts 96%
- Molecular estimation of neurodegeneration pseudotime in older brains 95%
- A human single-cell atlas of the Substantia nigra reveals novel cell-specific pathways associated with the genetic risk of Parkinson's disease and neuropsychiatric disorders. 94%
Similar papers in this journal
- Zero-shot drug repurposing with geometric deep learning and clinician centered design 94%
- Synapse protein signatures in cerebrospinal fluid and plasma predict cognitive maintenance versus decline in Alzheimers disease 93%
- Human loss-of-function variants suggest that partial LRRK2 inhibition is a safe therapeutic strategy for Parkinsons disease 93%
Similar papers in this journal
- Federated Target Trial Emulation using Distributed Observational Data for Treatment Effect Estimation 93%
- Crowdsourcing digital health measures to predict Parkinson's disease severity: the Parkinson's Disease Digital Biomarker DREAM Challenge 93%
- Few shot learning for phenotype-driven diagnosis of patients with rare genetic diseases 92%
Similar papers in this journal
- Defining and predicting transdiagnostic categories of neurodegenerative disease 95%
- Neuroimaging-AI Endophenotypes of Brain Diseases in the General Population: Towards a Dimensional System of Vulnerability 94%
- Combinatorial prediction of therapeutic perturbations using causally-inspired neural networks 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.